Mark Talamonti to Carcinoembryonic Antigen
This is a "connection" page, showing publications Mark Talamonti has written about Carcinoembryonic Antigen.
Connection Strength
0.054
-
NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer. Anticancer Res. 1999 Jul-Aug; 19(4A):2411-4.
Score: 0.044
-
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer. 1998 Apr 01; 82(7):1250-9.
Score: 0.010